Parametric Portfolio Associates’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$1.14M Sell
114,766
-34,989
-23% -$371K ﹤0.01% 2721
2021
Q4
$1.76M Buy
149,755
+79,609
+113% +$978K ﹤0.01% 2509
2021
Q3
$799K Buy
70,146
+4,558
+7% +$59.4K ﹤0.01% 2898
2021
Q2
$914K Sell
65,588
-6,555
-9% -$99.6K ﹤0.01% 2813
2021
Q1
$1.33M Buy
72,143
+4,974
+7% +$102K ﹤0.01% 3025
2020
Q4
$1.19M Buy
67,169
+30,913
+85% +$543K ﹤0.01% 2958
2020
Q3
$555K Buy
36,256
+3,222
+10% +$60.5K ﹤0.01% 3222
2020
Q2
$842K Sell
33,034
-7,498
-18% -$157K ﹤0.01% 3008
2020
Q1
$627K Sell
40,532
-18,325
-31% -$287K ﹤0.01% 3041
2019
Q4
$651K Buy
58,857
+7,285
+14% +$63.3K ﹤0.01% 3269
2019
Q3
$439K Buy
51,572
+19,977
+63% +$221K ﹤0.01% 3389
2019
Q2
$428K Buy
31,595
+4,787
+18% +$74.3K ﹤0.01% 3423
2019
Q1
$484K Buy
26,808
+4,243
+19% +$82K ﹤0.01% 3353
2018
Q4
$634K Sell
22,565
-1,357
-6% -$28.3K ﹤0.01% 3208
2018
Q3
$610K Buy
23,922
+7,218
+43% +$140K ﹤0.01% 3335
2018
Q2
$290K Buy
+16,704
New +$302K ﹤0.01% 3566

Other funds holding KNSA